2rkd Citations

Differential inhibition of cytosolic PEPCK by substrate analogues. Kinetic and structural characterization of inhibitor recognition.

Biochemistry 47 2099-109 (2008)
Related entries: 2rk7, 2rk8, 2rka, 2rke

Cited: 19 times
EuropePMC logo PMID: 18197707

Abstract

The mechanisms of molecular recognition of phosphoenolpyruvate (PEP) and oxaloacetate (OAA) by cytosolic phosphoenolpyruvate carboxykinase (cPEPCK) were investigated by the systematic evaluation of a variety of PEP and OAA analogues as potential reversible inhibitors of the enzyme against PEP. The molecules that inhibit the enzyme in a competitive fashion were found to fall into two general classes. Those molecules that mimic the binding geometry of PEP, namely phosphoglycolate and 3-phosphonopropionate, are found to bind weakly (millimolar Ki values). In contrast, those competitive inhibitors that mimic the binding of OAA (oxalate and phosphonoformate) coordinate directly to the active site manganese ion and bind an order of magnitude more tightly (micromolar Ki values). The competitive inhibitor sulfoacetate is found to be an outlier of these two classes, binding in a hybrid fashion utilizing modes of recognition of both PEP and OAA in order to achieve a micromolar inhibition constant in the absence of direct coordination to the active site metal. The kinetic studies in combination with the structural characterization of the five aforementioned competitive inhibitors demonstrate the molecular requirements for high affinity binding of molecules to the active site of the enzyme. These features include cis-planar carbonyl groups that are required for coordination to the active site metal, a bridging electron rich atom at the position corresponding to the C2 methylene group of OAA to facilitate interactions with R405, a carboxylate or sulfonate moiety at a position corresponding to the C1 carboxylate of OAA, and the edge-on aromatic interaction between a carboxylate and Y235.

Articles - 2rkd mentioned but not cited (1)

  1. Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy. Baptista LPR, Sinatti VV, Da Silva JH, Dardenne LE, Guimarães AC. Adv Appl Bioinform Chem 12 15-32 (2019)


Reviews citing this publication (2)

Articles citing this publication (16)

  1. Enzymes with lid-gated active sites must operate by an induced fit mechanism instead of conformational selection. Sullivan SM, Holyoak T. Proc. Natl. Acad. Sci. U.S.A. 105 13829-13834 (2008)
  2. Biophysical limits of protein-ligand binding. Smith RD, Engdahl AL, Dunbar JB, Carlson HA. J Chem Inf Model 52 2098-2106 (2012)
  3. The Ω-loop lid domain of phosphoenolpyruvate carboxykinase is essential for catalytic function. Johnson TA, Holyoak T. Biochemistry 51 9547-9559 (2012)
  4. Increasing the conformational entropy of the Omega-loop lid domain in phosphoenolpyruvate carboxykinase impairs catalysis and decreases catalytic fidelity . Johnson TA, Holyoak T. Biochemistry 49 5176-5187 (2010)
  5. Electrostatic interactions play a significant role in the affinity of Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase for Mn2+. Sepúlveda C, Poch A, Espinoza R, Cardemil E. Biochimie 92 814-819 (2010)
  6. Grapefruit juice improves glucose intolerance in streptozotocin-induced diabetes by suppressing hepatic gluconeogenesis. Hayanga JA, Ngubane SP, Murunga AN, Owira PMO. Eur J Nutr 55 631-638 (2016)
  7. Whiskers-less HIV-protease: a possible way for HIV-1 deactivation. Dayer MR, Dayer MS. J. Biomed. Sci. 20 67 (2013)
  8. Dynamic behavior of rat phosphoenolpyruvate carboxykinase inhibitors: new mechanism for enzyme inhibition. Dayer MR, Dayer MS, Ghayour O. Protein J. 32 253-258 (2013)
  9. Functional evaluation of serine 252 of Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase. Castillo D, Sepúlveda C, Cardemil E, Jabalquinto AM. Biochimie 91 295-299 (2009)
  10. The natural DNA bending angle in the lac repressor headpiece-O1 operator complex is determined by protein-DNA contacts and water release. Barr D, van der Vaart A. Phys Chem Chem Phys 14 2070-2077 (2012)
  11. Comparison of Newly Assembled Full Length HIV-1 Integrase With Prototype Foamy Virus Integrase: Structure-Function Prospective. Dayer MR. Jundishapur J Microbiol 9 e29773 (2016)
  12. Mechanism of preferential packaging of negative sense genomic RNA by viral nucleoproteins in Crimean-Congo hemorrhagic Fever virus. Dayer MR, Dayer MS, Rezatofighi SE. Protein J. 34 91-102 (2015)
  13. Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach. Dayer MR, Dayer MS. Mol Biol Res Commun 3 253-267 (2014)
  14. Stereochemistry of the carboxylation reaction catalyzed by the ATP-dependent phosphoenolpyruvate carboxykinases from Saccharomyces cerevisiae and Anaerobiospirillum succiniciproducens. Pérez E, Espinoza R, Laiveniekcs M, Cardemil E. Biochimie 90 1685-1692 (2008)
  15. Inhibition of Pig Phosphoenolpyruvate Carboxykinase Isoenzymes by 3-Mercaptopicolinic Acid and Novel Inhibitors. Hidalgo J, Latorre P, Carrodeguas JA, Velázquez-Campoy A, Sancho J, López-Buesa P. PLoS ONE 11 e0159002 (2016)
  16. Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase: the relevance of Glu299 and Leu460 for nucleotide binding. Pérez E, Cardemil E. Protein J. 29 299-305 (2010)